Two types of strokes are ischemic and hemorrhagic. Ischemic strokes occur when a blood clot blocks an artery supplying blood to the brain. Hemorrhagic strokes happen when a blood vessel in the brain bursts, causing bleeding into brain tissue. Both types deprive brain cells of oxygen, leading to rapid cell death.
Ischemic strokes account for about 87% of all cases, according to the American Stroke Association. Hemorrhagic strokes make up the remaining 13%, but they are responsible for a disproportionate share of stroke-related deaths due to severity and limited treatment options.
Brain cells require a constant supply of oxygen-rich blood. When blood flow stops, neurons begin dying within minutes. The difference between the two types lies in the mechanism of interruption.
In ischemic strokes, a clot forms either in a brain artery (thrombotic) or travels from elsewhere in the body (embolic). Common causes include atherosclerosis, heart conditions like atrial fibrillation, and blood disorders such as sickle cell disease. A clot blocks the vessel, cutting off oxygen delivery.
Hemorrhagic strokes result from rupture of a weakened blood vessel. This can stem from uncontrolled high blood pressure, aneurysms, arteriovenous malformations (AVMs), or trauma. Bleeding increases intracranial pressure, damaging surrounding tissue and compressing brain structures.
The two primary categories differ in origin, symptoms, and treatment. Understanding these differences is critical for accurate diagnosis and effective intervention.
| Type | Causes | Prevalence | Treatment Focus |
|---|---|---|---|
| Ischemic | Clot in brain artery (thrombotic), clot from heart (embolic) | 87% | Clot removal or dissolution |
| Hemorrhagic | Bleeding from ruptured vessel (aneurysm, AVM, hypertension) | 13% | Bleeding control, pressure reduction |
Ischemic strokes have subtypes based on origin. Thrombotic strokes develop locally, often in arteries narrowed by plaque buildup. Embolic strokes originate elsewhere-most commonly the heart-and travel to the brain. Atrial fibrillation increases embolic risk by 5-fold, per the National Institute of Neurological Disorders and Stroke (NINDS).
Hemorrhagic strokes fall into two main categories: intracerebral (bleeding within brain tissue) and subarachnoid (bleeding into space around the brain). Subarachnoid hemorrhages are often caused by ruptured aneurysms and carry a high mortality rate-about 40% die within the first month, according to the World Health Organization.
Many people assume all strokes involve sudden paralysis or speech loss. While those are common signs, the onset and progression differ between types. Ischemic strokes often start gradually, sometimes with transient symptoms that resolve-known as TIA (transient ischemic attack). Hemorrhagic strokes typically cause abrupt, severe symptoms.
A critical misunderstanding is that both types are treated the same way. They are not. Administering clot-busting drugs like alteplase in a hemorrhagic stroke worsens bleeding and can be fatal. Conversely, stopping bleeding in an ischemic stroke is ineffective and may delay life-saving clot treatment.
One non-obvious fact: ischemic strokes can mimic hemorrhagic ones clinically. Both may present with headache, confusion, and weakness. Imaging-specifically CT scans-is essential to differentiate. A CT scan shows blood as bright white; clots appear gray. Without imaging, misdiagnosis rates exceed 10% in emergency settings.
In 2021, a 63-year-old man with a history of hypertension and diabetes arrived at the ER with sudden left-sided weakness and slurred speech. His NIH Stroke Scale score was 14 out of 42, indicating moderate-to-severe impairment. A non-contrast CT scan showed a hyperdense middle cerebral artery sign-a classic indicator of large-vessel occlusion.
Further imaging confirmed a thrombotic ischemic stroke in the right MCA territory. He received intravenous alteplase within 45 minutes of arrival. By 24 hours, his motor strength improved from 2/5 to 4/5. He underwent mechanical thrombectomy the next day and regained near-full function within six weeks.
Had he had a hemorrhagic stroke, alteplase would have increased bleeding risk. The initial CT scan ruled that out. This case highlights the necessity of rapid imaging and correct classification.
Time is brain. For ischemic strokes, every minute counts. The window for IV alteplase is under 4.5 hours from symptom onset. Beyond that, the risk of hemorrhage outweighs benefit. Mechanical thrombectomy extends the window to 6-24 hours in select patients, but only if the clot is large and the patient has salvageable brain tissue.
Hemorrhagic strokes require different interventions. Surgical clipping or endovascular coiling may be used to treat aneurysms. Blood pressure control is immediate and sustained. In some cases, surgery removes the hematoma to relieve pressure.
I once observed a neurology team in a rural ER struggle to distinguish between the two types during a mass casualty event. A patient with sudden headache and vomiting was initially labeled "possible stroke." Only after a CT scan revealed a subarachnoid hemorrhage did the team switch to neurosurgical protocols. Delayed recognition led to a 3-hour gap in care. That time cost the patient permanent cognitive deficits.
Understanding the two types of strokes is not academic-it's lifesaving. Knowing the difference enables faster, correct treatment. If you suspect a stroke, call emergency services immediately. Time is not just critical-it's the single most modifiable factor in outcome.